Navigation Links
MQ Associates, Inc. Announces Cash Tender Offer for 121/4% Senior Discount Notes Due 2012 (CUSIP No. 55345RAC2) and Related Consent Solicitation
Date:12/31/2007

to sell or the solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale of any securities in any jurisdiction in which such offering, solicitation or sale would be unlawful.

Forward Looking Statements

This press release contains or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, without limitation, statements regarding MQ Associates' future growth and profitability, growth strategy and trends in the industry in which it operates. These forward-looking statements are based on MQ Associates' current expectations and are subject to a number of risks, uncertainties and assumptions. MQ Associates can give no assurance that such forward-looking statements will prove to be correct. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are the recently closed merger with Novant, general economic and business conditions, the effect of healthcare industry trends on third-party reimbursement rates and demand for its services, limitations and delays in reimbursement by third- party payors, changes in governmental regulations that affect its ability to do business, actions of its competitors, introduction of new technologies, risks associated with its acquisition strategy and integration costs, and the additional factors and risks contained in MQ Associates' Annual Report on Form 10-K for the year ended December 31, 2006, as well as its other periodic reports filed with the SEC. MQ Associates undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as otherwise required by law.

MedQuest is a leading operator of independent, fixed-site, outpatient diagnostic imaging centers in the United States. MedQuest centers provide hig
'/>"/>

SOURCE MQ Associates, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
2. Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer
3. MQ Associates, Inc. Announces Results for the Third Quarter and Nine Months Ended September 30, 2007
4. National HealthCare Recognized for Outstanding Sales Leadership by Long Term Care Associates, Inc.
5. MQ Associates, Inc. Announces Expiration of its Tender Offers for its 12 1/4% Senior Discount Notes Due 2012 (CUSIP No. 55345RAC2) and Medquest, Inc.s 11 7/8% Senior Subordinated Notes Due 2012 (CUSIP No. 58505DAD1)
6. Shareholder Class Action Filed Against Health Management Associates, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
7. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
8. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
9. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
10. HEI, Inc. Announces Sale of RFID Division Assets
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... Today’s ... managerial expertise to oversee large healthcare operations and their success is determined ... insurance companies, and regulators. American Sentinel University, an innovative, accredited provider of ...
(Date:7/7/2015)... ... 07, 2015 , ... Nationally-renowned attorneys in the realm of ... Invokana Ketoacidosis Lawsuit Center . The website provides information on Invokana side ... wishing to learn more about Invokana lawsuits for kidney problems, ketoacidosis, heart attack, ...
(Date:7/7/2015)... Tennessee (PRWEB) , ... July 07, 2015 , ... Connexion Point is holding an onsite ... will be held at 1769 Paragon Place, Suite 100, this upcoming Wednesday, July 8, and ... job fair, Connexion Point will be recruiting new applicants as well as holding onsite interviews. ...
(Date:7/7/2015)... ... July 07, 2015 , ... Each year the Holiday Inn ... on a local, national and international level; however, the Holiday Inn now hosts one ... a high impact on the beneficiaries. In September of 2014 they hosted an event ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... pre-clinical stages of drug discovery. iPSCs are generated from adult cells, such as ... any cell type in the human body. , iPSC-derived cardiomyocytes ...
Breaking Medicine News(10 mins):Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 3Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 4Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3Health News:Connexion Point, a tech enabled healthcare services company, is holding on-site job fair July 8th and 9th to fill 400 positions at its new Memphis location 2Health News:The Holiday Inn Westbury - Long Island Will Host a Fundraising Event on September 16th 2015 from 6:00 pm - 10:00 pm to Benefit Angela's House located on Long Island 2Health News:The Holiday Inn Westbury - Long Island Will Host a Fundraising Event on September 16th 2015 from 6:00 pm - 10:00 pm to Benefit Angela's House located on Long Island 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4
... created by a team of Purdue University researchers ... could have broad applications ranging from plant root ... The self-referencing optrode, developed in the lab ... and biological engineering, is non-invasive, can deliver real-time ...
... smoking produces rapid and substantial reductions in community rates ... in Circulation , the journal of the American ... in North America, Italy, Scotland and Ireland and, despite ... hospitalisation for heart attack (acute myocardial infarction, AMI) of ...
... , GENEVA and GREAT NECK, N.Y., ... ("Neogenix") today jointly announced a Research Services Agreement ... cell line expressing an undisclosed Neogenix antibody. The cell ... leading Selexis SURE Cell Line Development(TM) Platform. , ...
... NEW YORK, Sept. 22 Moroney & Gill, Inc. launches ... Moroney, President and CEO, states: "Advertising agencies, in order to ... and not be afraid to tailor their services to the ... market (ie: neurotoxins, injectable fillers, etc.), and the anticipated growth ...
... new treatments or even a cure, researchers say , TUESDAY, ... are associated with glaucoma in blacks, say researchers who studied ... lead to new treatments or a cure, the scientists added. ... affecting close to 5 percent of the population. There is ...
... , , SEATTLE, Sept. 22 ... firms, announced today that it has opened a new office in ... offices, will continue to serve existing clients while expanding the range ... "Milliman,s wide range of talents and sixty-plus years of experience ...
Cached Medicine News:Health News:New multi-use device can shed light on oxygen intake 2Health News:A consistent decline in heart attack rates following the implementation of smoking bans 2Health News:A consistent decline in heart attack rates following the implementation of smoking bans 3Health News:Selexis and Neogenix Oncology Announce Agreement on Antibody Project 2Health News:Glaucoma Tied to Gene Variants in Blacks 2Health News:Milliman Announces the Opening of a New Office in San Juan, Puerto Rico 2
(Date:7/6/2015)... 2015 Celtaxsys, Inc., a clinical stage pharmaceutical ... rare and orphan inflammatory disease indications, announced today that ... Drug Administration (FDA) to begin a Phase 2 clinical ... adult CF patients in the US. The regulatory submissions ... will be filed soon after. This groundbreaking clinical ...
(Date:7/6/2015)... SOUTH SAN FRANCISCO, Calif. , July ... ), a leading global pharmaceutical company, and Oculeve, a ... for dry eye disease, today announced that they have ... Oculeve in an all-cash transaction.  Under the terms of ... million upfront payment and commercialization milestone payments related to ...
(Date:7/6/2015)... -- China Information Technology, Inc. (the "Company" or "CNIT") ... platform, exchange, and big data solutions in ... its mobile app for Healthcare One Pass, ushering in ... devices. The Company jointly hosted the launch ceremony with ... Shenzhen News Net.   The mobile app for ...
Breaking Medicine Technology:Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 4CNIT Launches the Mobile App for Healthcare One Pass 2CNIT Launches the Mobile App for Healthcare One Pass 3CNIT Launches the Mobile App for Healthcare One Pass 4
... ... Anticancer Drug, HOUSTON, ... to families, workplaces and communities, and many,Houstonians are aware of ... the CHRISTUS Stehlin Foundation for,Cancer Research, a nationally recognized leader ...
Journalists and other readers should disregard the news release "Oramed,Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository",OTC:ORMP, issued earlier today. The release was transmitted...
Cached Medicine Technology:Local Research Foundation Achieves Milestone in Fight Against Cancer 2Local Research Foundation Achieves Milestone in Fight Against Cancer 3
... Split Splint reduces PIP joint or DIP joint ... to put on. Soft gel-lining cushions injured fingers ... begin earlier for faster, more successful therapy results. ... and at night to maintain gains in motion. ...
... FoamWrap Final Flexion Wraps restore full PIP ... or when lost due to arthritic changes. ... foam-lined material hugs the finger to prevent ... restore motion. One size. Sold in packages ...
One splint does it all....
... of minor knee pain like arthritis, tendonitis ... with the motion of the knee, applying ... tendon and assisting in the relief of ... with high density foam padding molds itself ...
Medicine Products: